Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
16.51
-0.29 (-1.73%)
Mar 9, 2026, 3:06 PM EDT - Market open
Eton Pharmaceuticals Employees
Eton Pharmaceuticals had 31 employees as of December 31, 2024. The number of employees increased by 1 or 3.33% compared to the previous year.
Employees
31
Change (1Y)
1
Growth (1Y)
3.33%
Revenue / Employee
$2,268,258
Profits / Employee
-$215,548
Market Cap
442.76M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Canopy Growth | 960 |
| Emergent BioSolutions | 900 |
| Organogenesis Holdings | 854 |
| Kamada | 420 |
| Lifecore Biomedical | 406 |
| Evolus | 334 |
| Esperion Therapeutics | 304 |
| Ironwood Pharmaceuticals | 253 |
ETON News
- 5 days ago - Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 19, 2026 - GlobeNewsWire
- 7 days ago - Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL® (propranolol hydrochloride) Oral Solution - GlobeNewsWire
- 12 days ago - US FDA approves Eton Pharma's hormonal disorder drug - Reuters
- 12 days ago - Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA™ (desmopressin acetate) Oral Solution - GlobeNewsWire
- 17 days ago - Eton Pharmaceuticals to Participate at Leerink Partners Global Healthcare Conference on Wednesday, March 11th - GlobeNewsWire
- 5 weeks ago - Eton Pharmaceuticals Announces Licensing of Rare Disease Product Candidate - GlobeNewsWire
- 6 weeks ago - Eton Pharmaceuticals: An Undervalued Small Cap With High Growth - Seeking Alpha
- 3 months ago - Eton Pharmaceuticals to Present at Piper Sandler 37th Annual Healthcare Conference on December 4th - GlobeNewsWire